About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

ProPhase Arbitration Ruling Handed Down

November 16, 2016

Click here to read more

Post navigation

Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan

Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete

Related Posts

TGA pre-submission meeting for insomnia related CBD soft-gel product

May 26, 2021May 26, 2021

Oxymorphone Patch Program Update

May 14, 2015

Phosphagenics Signs Term Sheet for TPM Diclofenac Gel in Asia

September 26, 2017

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.